Status:
COMPLETED
Effectiveness of a Stress Reduction Intervention in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Stress, Psychological
Caregivers
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Background: \- People who have an allogeneic hematopoietic stem cell transplant (HSCT) need help as they recover. Being a caregiver can be stressful to the body and mind. Researchers want to find way...
Detailed Description
Millions of Americans provide unpaid care for aging or ill family members and friends. Caregiving for an individual with cancer who is undergoing stem cell transplantation is particularly stressful. T...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age greater than or equal to 18 years old
- Ability to comprehend the investigational nature of the study
- Able to read and speak English
- Agrees to participate in the study
- Able to lift arms over head without pain
- Able to sit and stand from a seated position unassisted
- Intends to serve as an active caregiver\* for a patient undergoing their 1st allogeneic HSCT at the NIH Clinical Center
- EXCLUSION CRITERIA:
- Age less than or equal to 18 years old
- Pregnant or lactating women
- Inability to comprehend investigational nature of study
- Inability to provide informed consent
- Unable to read and speak English
- Does not agree to participate in study or follow study design
- Serving as a paid caregiver for any individual
- Regular practitioner of yoga, meditation or other mind-body practice (definition: taking classes or practicing at least weekly for at least 2 of the past 6 months).
- Physical function limitations that would interfere with intervention
- Caregiver participants will be excluded from the biomarker analysis if they have had:
- Glucocorticosteroid treatment in the last 2 months
- Have a recent (within the last 2 months) acute illness or injury
- Have served as a stem cell transplant donor or have taken filgastrim
Exclusion
Key Trial Info
Start Date :
January 5 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 7 2019
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT02257853
Start Date
January 5 2015
End Date
February 7 2019
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892